R. Boulmé

发表

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

Corinne Alberti, Antonio Artigas, Ronan Boulmé, 2002, Intensive Care Medicine.

Effect of pulmonary tuberculosis on mortality in patients receiving HAART

D. Westreich, I. Sanne, J. Eron, 2009, AIDS.

Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains.

V. Arendt, J. Schmit, R. Boulmé, 2003, Journal of acquired immune deficiency syndromes.

Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients

N. Clumeck, S. De Wit, J. Schmit, 2004, AIDS.

Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure

Ronan Boulmé, Dimitri Gonzalez, Daniel Olive, 2014, AIDS.

From Capillary Electrophoresis to Deep Sequencing: An Improved HIV-1 Drug Resistance Assessment Solution Using In Vitro Diagnostic (IVD) Assays and Software

C. Sayada, R. Boulmé, Sofiane Mohamed, 2023, Viruses.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Erratum to: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

J. le Gall, C. Brun-Buisson, R. Moreno, 2002, Intensive Care Medicine.

Comparison of HIV type 1 protease inhibitor susceptibility results in viral samples analyzed by phenotypic drug resistance assays and by six resistance algorithms: an analysis of a subpopulation of the CHORUS cohort.

R. Boulmé, G. Fusco, A. Florance, 2005, AIDS research and human retroviruses.

Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients

F. Clavel, P. Clevenbergh, J. Schmit, 2002, HIV clinical trials.

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure

D. Olive, P. Halfon, G. Pénaranda, 2014, BMC Infectious Diseases.

Efficacy, safety and predictive factors of virological success of a boosted amprenavir‐based salvage regimen in heavily antiretroviral‐experienced HIV‐1‐infected patients

P. Clevenbergh, R. Boulmé, P. Dellamonica, 2004, HIV medicine.

Patients' preferences concerning medical information and surrogacy: results of a prospective study in a French emergency department

E. Roupie, A. Santin, R. Boulmé, 2000, Intensive Care Medicine.

A direct comparison of drug susceptibility to HIV type 1 from antiretroviral experienced subjects as assessed by the antivirogram and PhenoSense assays and by seven resistance algorithms.

J. Schmit, R. Boulmé, A. Florance, 2005, AIDS research and human retroviruses.

P14: HepatiC, the viral hepatitis C patients management application and database

M. Buti, X. Forns, J. Calleja, 2013 .